NVO - NOVO NORDISK A S

QQQ $ 469.07 $ 0.44 (0.09 %)

DIA $ 409.12 $ -0.34 (-0.08 %)

SPY $ 554.50 $ -0.49 (-0.09 %)

TLT $ 100.09 $ -0.28 (-0.28 %)

GLD $ 235.99 $ 1.35 (0.58 %)

Previous Close

$ 135.23

Open

$ 135.24

Bid

$ 135.11 x 100

Ask

$ 135.17 x 100

Day's Range

$ 135.24 - $ 136.00

52 Week Range

$ 86.02 - $ 147.60

Volume

3,930,305

Average Volume

Market Cap

609,887

Beta (5Y Monthly)

$ 0.67

PE Ratio (TTM)

$ 0.00

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.01)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

if-you-invested-1000-in-this-stock-10-years-ago-you-would-have-5700-today

If You Invested $1000 In This Stock 10 Yea...
09/11/2024 18:30:58

Roche Says In CT-996 Phase 1 Trial, 4-Week...
09/11/2024 15:49:52

- Reuters

ozempic-maker-novo-nordisk-touts-encouraging-data-from-new-obesity-pill-showing-double-weight-loss-compared-to-wegovy

Ozempic Maker Novo Nordisk Touts Encouragi...
09/11/2024 13:13:52

Novo Nordisk presented data on its next-generation weight-loss candidate, amycretin, which showed a significant 13% weight loss...

novo-nordisk-reports-positive-results-of-weight-loss-drug-liraglutide-for-children-as-young-as-6-eyes-fda-and-ema-approval

Novo Nordisk Reports Positive Results Of W...
09/11/2024 08:19:30

Novo Nordisk has announced that its weight-loss drug liraglutide is safe and effective for children as young as six. The compan...

Evaluating Novo Nordisk: Insights From 8 F...
09/09/2024 17:00:42

Cantor Fitzgerald Reiterates Overweight on...
09/09/2024 15:50:36

Cantor Fitzgerald analyst Louise Chen reiterates Novo Nordisk (NYSE:NVO) with a Overweight and maintains $160 price target.

what-the-options-market-tells-us-about-novo-nordisk

What the Options Market Tells Us About Nov...
09/06/2024 16:16:15

goldman-sachs-shifts-stance-on-novartis-cites-lack-of-near-term-catalysts

Goldman Sachs Shifts Stance On Novartis, C...
09/05/2024 18:34:15

Goldman Sachs downgrades Novartis to Neutral, citing a lack of immediate innovative catalysts and limited stock growth potential.

fake-ozempic-targets-weight-loss-market-forged-batches-an-international-concern

Fake Ozempic Targets Weight-Loss Market: F...
09/05/2024 17:17:20

Criminals distribute fake Ozempic by forging batch numbers. Novo Nordisk suspects one source in global counterfeiting operation...

battle-over-compounded-weight-loss-medications---sustainability-and-regulation

Battle Over Compounded Weight-Loss Medicat...
09/05/2024 16:47:47

Explore how Hims & Hers competes with big pharma amid weight-loss drug shortages, offering cheaper alternatives and facing ...

Novo Nordisk Unusual Options Activity
09/05/2024 15:32:05

ascendis-pharma-faces-challenges-with-skytrofa-and-yorvipath-pricing-analysts-weigh-in

Ascendis Pharma Faces Challenges With Skyt...
09/04/2024 21:02:35

Ascendis Pharma reported disappointing Q2 sales of $38.76 million, missing the consensus of $92.7 million. Key updates included...

bioage-labs-files-for-100m-ipo-becomes-the-new-entrant-in-obesity-drugs-race

BioAge Labs Files For $100M IPO, Becomes T...
09/04/2024 15:13:09

BioAge Labs a biotech company focused on therapies for metabolic diseases, has filed for a $100 million IPO. Founded in 2015, t...

MHRA Finds No Evidence Supporting Link Bet...
09/04/2024 14:52:07

- Reuters

despite-medicare-negotiations-americans-may-still-have-to-pay-more-for-prescription-drugs

Despite Medicare Negotiations, Americans M...
09/03/2024 19:12:09

Despite Medicare's first-ever negotiated drug prices under the Inflation Reduction Act, U.S. costs remain significantly hig...

10-health-care-stocks-with-whale-alerts-in-todays-session

10 Health Care Stocks With Whale Alerts In...
09/03/2024 17:35:17

eli-lilly-launches-discounted-mounjaro-and-zepbound-as-fight-against-compounded-imitations-escalates-amid-ongoing-fda-shortage-status-debate

Eli Lilly Launches Discounted Mounjaro And...
09/02/2024 07:43:18

Eli Lilly is intensifying its efforts to combat imitation versions of its popular appetite-suppressing drugs, Mounjaro and Zepb...

ozempic-unexpected-anti-aging-miracle-drug-researchers-reveal-surprising-potential

Ozempic: Unexpected Anti-Aging Miracle Dru...
08/31/2024 19:30:16

Ozempic may offer unexpected anti-aging benefits, potentially improving health and reducing mortality rates, according to new r...

judges-early-ruling-may-shape-outcome-in-ozempic-wegovy-lawsuits

Judge's Early Ruling May Shape Outcome In ...
08/30/2024 17:38:20

A Philadelphia judge's early ruling in the Ozempic and Wegovy litigation may shape the outcome of the lawsuits against Novo...

novo-nordisk-touts-encouraging-wegovy-data-to-lower-risk-of-severe-complications-in-heart-failure-patients

Novo Nordisk Touts Encouraging Wegovy Data...
08/30/2024 13:54:13

Novo Nordisk's semaglutide reduced the risk of cardiovascular events in heart failure patients by 31% in recent trials publ...